Pathophysiology and Molecular Research in Lymphedema

Babak J. Mehrara,Joseph H. Dayan,Michelle Coriddi,Raghu P. Kataru
DOI: https://doi.org/10.1016/b978-0-323-69418-6.00004-4
2022-01-01
Abstract:Secondary lymphedema is the most common long-term complication of cancer treatment and a significant source of morbidity. However, progress in developing novel therapies for lymphedema has been hampered by a lack of detailed understanding of the pathophysiology of the disease. Recent studies have shown that chronic inflammation, fibrosis, and disturbances in lymphangiogenesis play a key role in the development of lymphedema. This chapter will summarize the current understanding of these aspects of secondary lymphedema.
What problem does this paper attempt to address?